semaglutide 2 mg/1.5ml Ozempic® (semaglutide) GLP-1 RA for Type Diabetes Ozempic® (semaglutide) injection 0.5 mg,

GLP-1 receptor agonists in neurological diseases: mechanisms and therapeutic prospects from metabolism to neuroprotection

2026 Healthline Media LLC

Notably, while total FOXO4 protein levels remained consistent between young and elderly men, a striking age-dependent shift in its subcellular localization was observed: FOXO4 predominantly resided in the cytoplasm in young Leydig cells but translocated to the nucleus in aged cells

Wegovy (semaglutide) The Established Weekly Injectable or Oral Medication Wegovy is a once-weekly injectable GLP-1 receptor agonist with an established track record in clinical weight management